Chiquita Brooks-LaSure, CMS administrator (Chip Somodevilla/Getty Images)
May 6, 2024 03:15 PM EDT
Pharma
FDA+

In­dus­try groups cri­tique new guid­ance for Medicare drug price ne­go­ti­a­tions in 2027

Nicole DeFeudis

Editor

The Cen­ters for Medicare & Med­ic­aid Ser­vices pro­posed a num­ber of changes to its Medicare ne­go­ti­a­tion guid­ance on Fri­day, some of which would af­fect how …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times